The authors of this paper have advised us that by mistake they uploaded the wrong figure files for Figures 2 and 3 which had not been correctly updated.
In Figure 2 , the percentages within the figure do not match with what is reported in the text. As a result, they have provided the correct artwork below which should replace the existing image for Figure 2 in their paper.
In Figure 3 , to be consistent with Figure 2 , the author has changed just one label of one treatment group. As a result, they have provided the correct artwork below which should replace the existing image for Figure 3 in their paper. Figure 2 Bimekizumab efficacy in treating plaque psoriasis patients, assessed in a phase II trial. Clinical outcomes in psoriasis patients after 12-week therapy with placebo or different bimekizumab dosages. Abbreviations: BKZ, bimekizumab; BSA, body surface area; IGA, investigator global assessment; N, number; PASI, psoriasis area severity index; pts, patients; Q4, every 4 weeks; R, randomization; tot., total; w, weeks. 
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